Bayer’s Latest Roundup Trial Offers Better Chance of Winning (1)

Bayer AG went to trial Thursday over a California woman’s claims the company’s best-selling Roundup weedkiller caused her cancer in what could be the German conglomerate’s best shot at winning a case after three straight losses averaging almost $50 million in damages for each consumer.

Lawyers for Donnetta Stephens began laying out their claims to a jury that the 70-year-old woman developed non-Hodgkin’s Lymphoma after using Roundup for more than 30 years in her yard. It’s the first case against Bayer’s Monsanto unit to come to trial in more than two years after Covid-19 upended court schedules. Bayer’s attorneys were ...